Indegene Ltd
NSE:INDGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Indegene Ltd
Net Income (Common)
Indegene Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Indegene Ltd
NSE:INDGN
|
Net Income (Common)
4.1B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Abate As Industries Ltd
BSE:531658
|
Net Income (Common)
₹7.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
Premier Capital Services Ltd
BSE:511016
|
Net Income (Common)
-₹658k
|
CAGR 3-Years
38%
|
CAGR 5-Years
25%
|
CAGR 10-Years
29%
|
|
|
One Point One Solutions Ltd
NSE:ONEPOINT
|
Net Income (Common)
₹331.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Rudrabhishek Enterprises Ltd
NSE:REPL
|
Net Income (Common)
₹135.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
|
|
S
|
Sagility India Ltd
NSE:SAGILITY
|
Net Income (Common)
₹5.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indegene Ltd
Glance View
Indegene Ltd. is an intriguing tale of how technology and healthcare can converge to redefine industry standards. Established in 1998, this Bangalore-based company has strategically positioned itself at the intersection of life sciences, digital marketing, and healthcare solutions. Indegene capitalizes on providing tailored solutions to pharmaceutical and healthcare companies, leveraging its unique expertise in analytics, research, and digital innovation. With the constant need for improved healthcare delivery and a more personalized patient experience, Indegene addresses these demands by offering a comprehensive suite of services that includes medical, marketing, and managed care solutions. It helps its clients to navigate the complexities of regulatory landscapes, optimize pharmaceutical commercialization, and harness the power of data-driven medical research. The financial engine behind Indegene's success lies in its ability to seamlessly blend domain expertise with digital prowess. The company generates revenue primarily through long-term contracts with some of the world's leading life sciences companies. By providing strategic insights and operational execution in areas such as content management, omni-channel marketing, and commercialization strategy, Indegene empowers its clients to optimize their business processes, engage more effectively with healthcare professionals, and ultimately enhance patient outcomes. Its investment in building proprietary platforms and cutting-edge technology tools has enabled it to offer scalable, efficient solutions that are both cost-effective and inherently innovative, ensuring that Indegene remains a pivotal player in the ever-evolving healthcare landscape.
See Also
What is Indegene Ltd's Net Income (Common)?
Net Income (Common)
4.1B
Based on the financial report for Mar 31, 2025, Indegene Ltd's Net Income (Common) amounts to 4.1B .
What is Indegene Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
35%
Over the last year, the Net Income (Common) growth was 21%. The average annual Net Income (Common) growth rates for Indegene Ltd have been 35% over the past three years .